Unilateral Effects in Homogeneous Products: Same Product, Different Analysis? - An ABA Antitrust Program
Event | 04.24.14, 12:00 AM UTC - 12:00 AM UTC
The concept of unilateral effects in merger analysis is well-outlined in the 2010 Merger Guidelines and has been posited as a theory of harm by the agencies in cases involving both differentiated and homogeneous products. However, much of the debate and commentary regarding unilateral effects focuses on differentiated products. This program will explore potential merger analysis methodologies and an array of economic tools to employ when analyzing mergers involving homogeneous products.
For more information, please visit these areas: Corporate and Transactional
Insights
Event | 12.04.25
ACI 30th Annual Conference on Drug & Medical Device Litigation
Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.
Event | 11.04.25
